Kevin Cornwell is Chairman & CEO of UTAH MEDICAL PRODUCTS INC (UTMD). The company reported total compensation of $341,709 for fiscal year 2025.
| Salary | $87,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $0 |
| Non-equity incentive plan | $246,750 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $7,959 |
| Total | $341,709 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure UTAH MEDICAL PRODUCTS INC filed April 2, 2026, accession 0001096906-26-000477.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman & CEO | $87,000 | $0 | $0 | $0 | $246,750 | $0 | $7,959 | $341,709 |
| FY2024 | Chairman & CEO | $156,000 | $0 | $0 | $0 | $289,800 | $0 | $9,280 | $455,080 |
| FY2023 | Chairman & CEO | $152,000 | $0 | $0 | $0 | $349,650 | $0 | $8,920 | $510,570 |
Totals as disclosed in each year's own compensation disclosure for UTAH MEDICAL PRODUCTS INC.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Kevin Cornwell this page | Chairman & CEO | $341,709 |
| Brian Koopman | Principal Financial Officer | $179,077 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full UTAH MEDICAL PRODUCTS INC compensation brief.
Kevin Cornwell's compensation sits inside UTAH MEDICAL PRODUCTS INC's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.